SP sets criteria for access to cannabis-based medicines from SUS; see the rules

Patients should register prematurely with the State Health Department and submit a report and prescription for illnesses for which remedy has been proven to be helpful.

Jan 13
– 5:44 p.m

(up to date at 17:56)

Photo: Freepik

THE Legislative Assembly of Sao Paulo (Alesp) printed this Friday the thirteenth the regulation that ensures sufferers free access to medicines with cannabidiol pores and skin Unified well being system (SUS) in the state well being community. The textual content specifies that cannabinoid medicines should be pre-registered with the National Agency for Health Supervision (Anvisa) and in the nation of origin, a scientifically confirmed helpful impact and will likely be distributed solely with a medical report and a prescription justifying the remedy.

The regulation, which was accepted in late December and signed by the governor Tarsizio de Freitas (Republicans), goes into impact in 90 days and establishes a one-month interval starting this Friday for the State Health Department to implement any steerage supplied.

The folder can also be accountable for registering all sufferers – the kind should be obtainable on-line. In it, the individual should show that he doesn’t have the monetary situations to buy the remedy in the non-public community.

Medicines will solely be distributed for the remedy of illnesses for which the use of cannabinoids is indicated in International Classification of Diseases and Related Health Problems (CID). Scientific analysis lately has already proven that the substance brings advantages to autistic individuals, for instance with Parkinson’s, Alzheimer’s, epilepsy and uncommon illnesses.

Also in October, Federal Council of Medicine (CFM) issued a decision limiting the use and public dialogue of cannabinoids in Brazil. The measure prohibits medical doctors from giving lectures and programs on the use of cannabis-derived merchandise outdoors of a scientific setting.

Less than per week after the decision was printed, the CFM withdrew the choice after sturdy opposition from civil society and questioning by the Federal State Department. The group stated it might talk about the subject once more and open a brand new public session on the use of cannabinoids.

See the rules for accessing cannabinoid-based remedies from SUS in São Paulo:

  • The affected person should register prematurely with the State Health Department, which could be executed on-line, by e mail or delivered immediately to the folder constructing;
  • Registration could be executed in the identify of the affected person or a authorized consultant;
  • Only remedies with the most focus of tetrahydrocannabidiol permitted by Anvisa will likely be distributed;
  • The affected person should submit a report from a legally certified specialist containing the description of the case, the classification of the illness in the ICD, the rationale for utilizing a drug that’s not registered in Brazil, in contrast to present therapeutic options and the evolution with earlier remedies;
  • The affected person should additionally current a prescription for the drug from a legally competent specialist with the identify of the affected person and the drug, dosage, required quantity, time of remedy, date, signature and registration variety of the specialist registered in the class council;
  • It is critical for the affected person to signal a declaration of accountability and a proof for the emergency use of the drug

+The greatest content material in your e mail for free. Choose your favourite Terra e-newsletter. Press right here!


Leave a Reply

Your email address will not be published. Required fields are marked *